Neonatal screening for four lysosomal storage diseases with a digital microfluidics platform: Initial results in Brazil
AUTOR(ES)
Camargo Neto, Eurico, Schulte, Jaqueline, Pereira, Jamile, Bravo, Heydy, Sampaio-Filho, Claudio, Giugliani, Roberto
FONTE
Genet. Mol. Biol.
DATA DE PUBLICAÇÃO
04/06/2018
RESUMO
Abstract We describe the initial results of a neonatal screening program for four lysosomal storage diseases (MPS I, Pompe, Gaucher and Fabry) using the digital microfluidics methodology. The method successfully identified patients previously diagnosed with these diseases and was used to test dried blood spot samples obtained from 10,527 newborns aged 2 to 14 days. The digital microfluidic technology shows potential for a simple, rapid and high-throughput screening for these four diseases in a standard neonatal screening laboratory.
Documentos Relacionados
- Lysosomal Storage Diseases
- Bone Marrow Transplantation for Treatment of Lysosomal Storage Diseases
- Lysosomes, Lysosomal Storage Diseases, and Inflammation
- Sialic acid storage diseases. A multiple lysosomal transport defect for acidic monosaccharides.
- Relative frequency and estimated minimal frequency of Lysosomal Storage Diseases in Brazil: Report from a Reference Laboratory